Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pd-1 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04652440
What this trial is testing

Ablation Combined With PD-1 in HCC: Phase II Study

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 30
Early research (Phase 1)Looking for participantsNCT06398418
What this trial is testing

R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors

Who this might be right for
Solid Tumor, AdultSolid TumorMelanoma+3 more
Rise Therapeutics LLC 33
Testing effectiveness (Phase 2)UnknownNCT05501340
What this trial is testing

PD-1 Inhibitor Intraperitoneal Perfusion Combined With PRaG Therapy for Malignant Ascites

Who this might be right for
Malignant Ascites
Second Affiliated Hospital of Soochow University 40
Not applicableNot Yet RecruitingNCT07379489
What this trial is testing

Adjuvant Anti-PD-1 Therapy in Resected Hepatocellular Carcinoma

Who this might be right for
HCCAdjuvant TherapyRecurrence+1 more
Tongji Hospital 300
Large-scale testing (Phase 3)UnknownNCT05737563
What this trial is testing

PD-1 Antibody Combined With mXELIRI Versus mXELIRI in the Second-line Setting for ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma Abdominal Stage 0
Sun Yat-sen University 380
Testing effectiveness (Phase 2)Active Not RecruitingNCT05975307
What this trial is testing

Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation

Who this might be right for
Muscle-Invasive Bladder CarcinomaProgrammed Cell Death Protein 1 InhibitorRadiotherapy
Sun Yat-sen University 71
Early research (Phase 1)Active Not RecruitingNCT06377111
What this trial is testing

Test the Benefit of Vitamin B5 in Patients With Melanoma

Who this might be right for
Melanoma (Skin)
University Health Network, Toronto 12
Testing effectiveness (Phase 2)UnknownNCT04447326
What this trial is testing

Toripalimab, Endostar Combined With Radiotherapy and Chemotherapy for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
First Affiliated Hospital of Guangxi Medical University 106
Testing effectiveness (Phase 2)Study completedNCT04669899
What this trial is testing

Study of JTX-8064, as Monotherapy and in Combination With a PD-1 Inhibitor, in Adult Subjects With Advanced Refractory Solid Tumors

Who this might be right for
Cancer
Jounce Therapeutics, Inc. 190
Testing effectiveness (Phase 2)Looking for participantsNCT07125547
What this trial is testing

Neoadjuvant Tislelizumab + Nab-Paclitaxel Followed by Distal Ureterectomy for Ureteral Cancer

Who this might be right for
Ureteral CancerNeoadjuvant TherapyPD-1 Inhibitor+3 more
Tianjin Medical University Second Hospital 35
Testing effectiveness (Phase 2)UnknownNCT03557411
What this trial is testing

A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Hypofraction Radiotherapy in Patients With NSCLC

Who this might be right for
Non-Small-Cell Lung Cancer
Shandong Cancer Hospital and Institute 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07698587
What this trial is testing

A Phase Ib/II Study of BM230 in Combination With PD-1 Inhibitor for HER2-related Advanced Solid Tumors

Who this might be right for
Solid Tumor
Suzhou Biomissile Pharmaceuticals Co., Ltd. 90
Large-scale testing (Phase 3)Study completedNCT03361865
What this trial is testing

Pembrolizumab in Combination With Epacadostat or Placebo in Cisplatin-ineligible Urothelial Carcinoma (KEYNOTE-672/ECHO-307)

Who this might be right for
UC (Urothelial Cancer)
Incyte Corporation 93
Testing effectiveness (Phase 2)Study completedNCT03171064
What this trial is testing

Exercise as a Supportive Measure for Patients Undergoing Checkpoint-inhibitor Treatment

Who this might be right for
PD-1 AntibodiesExerciseMelanoma
University Hospital Heidelberg 39
Testing effectiveness (Phase 2)Ended earlyNCT05525455
What this trial is testing

TT-816 As Monotherapy or in Combination with a PD-1 Inhibitor in Patients with Advanced Cancers (SEABEAM) (MK3475-E88)

Who this might be right for
Advanced CancerAdvanced Solid TumorCancer+1 more
Teon Therapeutics, Inc. 9
Testing effectiveness (Phase 2)Study completedNCT03765229
What this trial is testing

An Exploratory Study of Pembrolizumab Plus Entinostat in Non-Inflamed Stage III/IV Melanoma

Who this might be right for
Melanoma
UNC Lineberger Comprehensive Cancer Center 11
Not applicableNot Yet RecruitingNCT07340502
What this trial is testing

TACE Versus HAIC, Combined With PD-1 Inhibitors and Lenvatinib for Unresectable Hepatocellular Carcinoma

Who this might be right for
HCC
Tongji Hospital 364
Not applicableLooking for participantsNCT05552846
What this trial is testing

Phase II Trial of Consolidative Thoracic Radiotherapy for ES-SCLC After Standard Care of Chemo-immunotherapy

Who this might be right for
Small-cell Lung Cancer
Ruijin Hospital 104
Testing effectiveness (Phase 2)Active Not RecruitingNCT05996523
What this trial is testing

Phase II Trial of Immunotherapeutic HPV Vaccine PRGN-2009 With Pembrolizumab Before Standard Treatment in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal Cancer

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma (SCC)
National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT05148546
What this trial is testing

Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer

Who this might be right for
Renal Cell Carcinoma
The Netherlands Cancer Institute 69
Next Page